Vancomycin architecture dependence on the capture efficiency of antibody-modified microbeads by magnetic nanoparticles.
We show that the ability to control the architecture/orientation of vancomycin on the surface of magnetic nanoparticles has a drastic effect on the ability of the nanoparticles to magnetically confine vancomycin-antibody modified polystyrene microbeads.
Kell
Arnold J
AJ
Steacie Institute for Molecular Sciences, National Research Council of Canada, 100 Sussex Drive, Ottawa, Ontario, Canada K1A 0R6.
Simard
Benoit
B
D000906:Antibodies / Q000737:chemistry*; D008280:Magnetics; D053758:Nanoparticles; D011137:Polystyrenes / Q000737:chemistry; D014640:Vancomycin / Q000737:chemistry*
D000906:Antibodies; D011137:Polystyrenes; D014640:Vancomycin